Resmed Inc. Stock
Resmed Inc. Stock
The Resmed Inc. stock is trending slightly upwards today, with an increase of €0.55 (0.300%) compared to yesterday's price.
With 20 Buy predictions and not the single Sell prediction the community is currently very high on Resmed Inc..
With a target price of 259 € there is a positive potential of 42.74% for Resmed Inc. compared to the current price of 181.45 €.
Pros and Cons of Resmed Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 0.300% | 7.264% | 6.100% | -25.525% | -13.237% | -10.667% | -21.073% |
| Veeva Systems A | 1.200% | 10.735% | 12.589% | -30.394% | -8.695% | -4.323% | -37.665% |
| Agilent Technologies Inc. | -1.700% | -2.076% | 3.484% | 16.367% | 2.628% | 5.249% | -6.345% |
| Boston Scientific | -1.040% | 4.098% | 6.787% | -57.388% | -51.001% | -14.939% | 3.732% |
Comments
ResMed (RMD) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $276.00 price target by Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $266.00 price target by KeyCorp. They now have an "overweight" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat